M. Paoloni and C. Khanna, Translation of new cancer treatments from pet dogs to humans, Nature Reviews Cancer, vol.11, issue.2, pp.147-56, 2008.
DOI : 10.1007/BF00830668

J. Rowell, D. Mccarthy, and C. Alvarez, Dog models of naturally occurring cancer, Trends in Molecular Medicine, vol.17, issue.7
DOI : 10.1016/j.molmed.2011.02.004
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130881/pdf

M. Paoloni, C. Webb, C. Mazcko, D. Cherba, W. Hendricks et al., Prospective Molecular Profiling of Canine Cancers Provides a Clinically Relevant Comparative Model for Evaluating Personalized Medicine (PMed) Trials, PLoS ONE, vol.3, issue.3, 2014.
DOI : 10.1371/journal.pone.0090028.s006

A. Leblanc, M. Breen, P. Choyke, M. Dewhirst, T. Fan et al., Perspectives from man's best friend: National Academy of Medicine's Workshop on Comparative Oncology, Sci Transl Med, vol.8, pp.324-329, 2016.

J. Schiffman and M. Breen, Comparative oncology: what dogs and other species can teach us about humans with cancer, Philosophical Transactions of the Royal Society B: Biological Sciences, vol.370, issue.1673, 2015.
DOI : 10.1098/rstb.2014.0222
URL : http://rstb.royalsocietypublishing.org/content/royptb/370/1673/20140231.full.pdf

G. Ranieri, I. Marech, M. Pantaleo, M. Piccinno, M. Roncetti et al., In vivo model for mastocytosis: A comparative review, Critical Reviews in Oncology/Hematology, vol.93, issue.3, pp.159-69, 2015.
DOI : 10.1016/j.critrevonc.2014.10.010

A. Greco, E. Roccato, C. Miranda, L. Cleris, F. Formelli et al., Growth-inhibitory effect of STI571 on cells transformed by theCOL1A1/PDGFB rearrangement, International Journal of Cancer, vol.53, issue.3, pp.354-60, 2001.
DOI : 10.1038/43474

F. Mertens, B. Johansson, T. Fioretos, and F. Mitelman, The emerging complexity of gene fusions in cancer, Nature Reviews Cancer, vol.360, issue.6, pp.371-81, 2015.
DOI : 10.1038/ng0895-436

M. Breen and J. Modiano, Evolutionarily conserved cytogenetic changes in hematological malignancies of dogs and humans ??? man and his best friend share more than companionship, Chromosome Research, vol.62, issue.1, pp.145-54, 2008.
DOI : 10.1511/2007.67.3724

M. Dhir, D. Crockett, T. Stevens, P. Silberstein, W. Hunter et al., Neoadjuvant treatment of Dermatofibrosarcoma Protuberans of pancreas with Imatinib: case report and systematic review of literature Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma, Clin Sarcoma Res. Nat Genet, vol.415, issue.11, pp.95-103, 1997.

I. Nakamura, Y. Kariya, E. Okada, M. Yasuda, S. Matori et al., Gene Fusion in Dermatofibrosarcoma Protuberans, JAMA Dermatology, vol.151, issue.12, pp.1330-1337, 2015.
DOI : 10.1001/jamadermatol.2015.2389

C. Penman, C. Faulkner, S. Lowis, and K. Kurian, Current Understanding of BRAF Alterations in Diagnosis, Prognosis, and Therapeutic Targeting in Pediatric Low-Grade Gliomas, Frontiers in Oncology, vol.50, issue.2, 2015.
DOI : 10.1016/j.ejca.2013.09.014

Y. Miyao, K. Shimizu, M. Tamura, H. Akita, K. Ikeda et al., Usefulness of a Mouse Myelin Basic Protein Promoter for Gene Therapy of Malignant Glioma: Myelin Basic Protein Promoter Is Strongly Active in Human Malignant Glioma Cells, Japanese Journal of Cancer Research, vol.75, issue.7, pp.678-86, 1997.
DOI : 10.1016/0378-1119(89)90380-6

H. Lo, Targeting Ras-RAF-ERK and its Interactive Pathways as a Novel Therapy for Malignant Gliomas, Current Cancer Drug Targets, vol.10, issue.8, pp.840-848, 2010.
DOI : 10.2174/156800910793357970
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615246/pdf

M. Badiali, V. Gleize, S. Paris, L. Moi, S. Elhouadani et al., Fusions and IDH Mutations Can Coexist in Diffuse Gliomas of Adults, Brain Pathology, vol.1, issue.6, pp.841-848, 2012.
DOI : 10.1002/path.2995

T. Sonoki, L. Harder, D. Horsman, L. Karran, I. Taniguchi et al., Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies, Blood, vol.98, issue.9, pp.2837-2881, 2001.
DOI : 10.1182/blood.V98.9.2837

F. Minnei, Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)- negative mantle cell lymphomas Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma, Blood. Clin Cancer Res Off J Am Assoc Cancer Res, vol.1118, issue.20, pp.5683-90729, 2002.